Ceftriaxone 250 mg Injection, marketed as Triazo 250, is a third-generation cephalosporin antibiotic used to treat bacterial infections. It works by disrupting bacterial cell wall synthesis, leading to bacterial death. Triazo 250 is administered intravenously or intramuscularly, providing broad-spectrum coverage against Gram-positive and Gram-negative organisms. It is prescribed for various infections, including respiratory tract infections, urinary tract infections, and septicemia, ensuring effective treatment under medical supervision.Available in PCD Franchise for injectable range and third party manufacturing.